Showing 2391-2400 of 7028 results for "".
Physician Dispensing: 7 Things Doctors Need to Know
https://practicaldermatology.com/topics/practice-management/physician-dispensing-7-things-doctors-need-to-know/23350/Physician dispensing provides a service to the patient while enhancing the practice. Here’s what you need to know.How to Use ChatGPT to Create a Social Media Content Calendar for Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-use-chatgpt-to-create-a-social-media-content-calendar-for-your-practice/23968/ChatGPT can help you ideate content and post it with consistency.Neuroimmune Parallels in Atopic Dermatitis and Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/neuroimmune-parallels-in-atopic-dermatitis-and-prurigo-nodularis/39667/Fighting for Coverage: Combatting Private Insurance to Get Patients the Drugs They Need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.The Impact of Clascoterone Topical Cream, 1%: The US Experience 4 Years After Approval and Clinical Expectations for Acne Patients in Other Regions of the World
https://practicaldermatology.com/topics/acne-rosacea/Impact-Clascoterone-Topical-Cream/32830/Clascoterone topical cream, 1% (Winlevi), approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older. The safety and efficacy were supported by two succeTopical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Physician Spotlight: Shawn Kwatra, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-shawn-kwatra-md/23997/Physician Spotlight: Lesley Clark-Loeser, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-lesley-clark-loeser-md/23980/Stand Out From the Pack
https://practicaldermatology.com/topics/practice-management/stand-out-from-the-pack/23975/How to get ahead of National Healthy Skin Month.Eradicating the Itch of Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/eradicating-the-itch-of-atopic-dermatitis/23947/Emerging treatments explore alternative pathways to stop itching at the source.